Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.

被引：0
|
作者：
Becker, Michael A. [1 ]
Baraf, Herbert S. B. [2 ]
Yood, Robert A. [3 ]
Dillon, Aileen M. [4 ]
Vazquez-Mellado, Janitzia [5 ]
Ottery, Faith D. [6 ]
Khanna, Dinesh [7 ]
Sundy, John S. [8 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Arthrit Rheumatism Associates, Wheaton, MD USA
[3] Reliant Med Grp, Worcester, MA USA
[4] Kaiser Fdn Hosp, San Francisco, CA USA
[5] Hosp Gen Mexico City, Mexico City, DF, Mexico
[6] Savient Pharmaceut Inc, E Brunswick, NJ USA
[7] Univ Michigan, Ann Arbor, MI 48109 USA
[8] Duke Univ, Med Ctr, Durham, NC USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
160
引用
收藏
页码：S69 / S70
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome in an open-label, Extension Trial
    Halford, Jonathan
    Scheffer, Ingrid
    Nabbout, Rima
    Sanchez-Carpintero, Rocio
    Malawsky, Yael Shiloh
    Wong, Matthew
    Checketts, Daniel
    VanLandingham, Kevan
    NEUROLOGY, 2019, 92 (15)
  • [32] Long-Term Safety and Efficacy of Voxelotor for Patients with Sickle Cell Disease: Results from an Open-Label Extension of the Phase 3 HOPE Trial
    Achebe, Maureen
    Hassab, Hoda
    Alkindi, Salam
    Brown, R. Clark Clark
    Telfer, Paul
    Biemond, Bart J.
    Gordeuk, Victor R.
    Lipato, Thokozeni
    Tonda, Margaret
    Gray, Sarah
    Howard, Joanna
    BLOOD, 2021, 138
  • [33] Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial
    Judge, Daniel P.
    Gillmore, Julian D.
    Alexander, Kevin M.
    Ambardekar, Amrut V.
    Cappelli, Francesco
    Fontana, Marianna
    Garcia-Pavia, Pablo
    Grodin, Justin L.
    Grogan, Martha
    Hanna, Mazen
    Masri, Ahmad
    Nativi-Nicolau, Jose
    Obici, Laura
    Hvitfeldt Poulsen, Steen
    Sarswat, Nitasha
    Shah, Keyur
    Soman, Prem
    Lystig, Ted
    Cao, Xiaofan
    Wang, Kevin
    Pecoraro, Maria Lucia
    Tamby, Jean-Francois
    Katz, Leonid
    Sinha, Uma
    Fox, Jonathan C.
    Maurer, Mathew S.
    CIRCULATION, 2025, 151 (09) : 601 - 611
  • [34] LONG-TERM SAFETY AND EFFICACY OF LACOSAMIDE AS ADJUNCTIVE THERAPY IN PATIENTS WITH UNCONTROLLED POS: RESULTS FROM A PHASE III OPEN-LABEL EXTENSION TRIAL
    Husain, A.
    Faught, E.
    Chung, S.
    Isojarvi, J.
    McShea, C.
    Doty, P.
    EPILEPSIA, 2011, 52 : 155 - 155
  • [35] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    MOVEMENT DISORDERS, 2017, 32
  • [36] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [37] Long-term safety of nebulized formoterol in COPD: An open-label active-controlled extension study
    Donohue, James F.
    Hamania, Nicola A.
    Fogarty, Charles M.
    Campbell, Saminy C.
    Denis-Mize, Kimberly
    Rinehart, Mike
    CHEST, 2007, 132 (04) : 531S - 531S
  • [38] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [39] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [40] Long-Term Efficacy and Safety with Lanreotide Autogel/ Depot (LAN) from CLARINET and Open-Label Extension (OLE) Studies
    Phan, A. T.
    Pavel, M.
    Caplin, M.
    Wolin, E. M.
    Mirakhur, B.
    Massien, C.
    Liyanage, N.
    Lowenthal, Pittman S.
    Ruszniewski, P.
    NEUROENDOCRINOLOGY, 2017, 105 : 207 - 207
12345